Related Experiment Videos
The hypolipidemic effects of 2-furoic acid in Sprague-Dawley rats
I H Hall1, O T Wong, D J Reynolds
1Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27759-7360.
Abstract:
2-Furoic acid was shown to be effective in lowering both serum cholesterol and serum triglyceride levels significantly in rats with an elevation of HDL cholesterol level at 20 mg/kg/day orally. LDL receptor activity was reduced in hepatocytes, aorta foam cells, small intestinal epithelium cells and fibroblasts. HDL receptor activity was elevated in the rat hepatocytes and small intestinal cells. These activities were correlated with inhibition of acyl CoA cholesterol acyl transferase activity. Neutral cholesterol ester hydrolase activity was elevated in rat hepatocytes and human fibroblasts. Thus, 2-furoic acid appears to interfere directly with activity of intracellular enzymes rather than affecting high affinity-mediated lipoprotein membrane receptors. In vivo treatment with 2-furoic acid led to reduction in the liver and small intestine ATP dependent citrate lyase, acetyl CoA synthetase, acyl CoA cholesterol acyl transferase, sn-glycerol 3-phosphate acyl transferase, phosphatidylate phosphohydrolase and heparin induced lipoprotein lipase activities. 2-Furoic acid reduced biliary cholesterol levels but the agent increased bile salts which are lithogenic. Acute toxicity studies in mice suggest that the agent has some hepatic toxicity effects. The LD50 was relatively low at 250 mg/kg IP in mice.
Insights
2-Furoic acid effectively lowers cholesterol and triglycerides in rats by inhibiting key intracellular enzymes involved in lipid metabolism. While beneficial for lipid profiles, it may cause hepatic toxicity and increase lithogenic bile salts.
Area of Science:
- Biochemistry
- Pharmacology
- Lipid Metabolism
Background:
- Elevated serum cholesterol and triglycerides are major risk factors for cardiovascular disease.
- Understanding the mechanisms of lipid-lowering agents is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the lipid-lowering effects and underlying mechanisms of 2-furoic acid.
- To assess the impact of 2-furoic acid on various enzymes involved in cholesterol and triglyceride metabolism.
- To evaluate the in vivo effects and potential toxicity of 2-furoic acid.
Main Methods:
- Oral administration of 2-furoic acid (20 mg/kg/day) to rats.
- Measurement of serum lipid levels (cholesterol, triglycerides, HDL).
- Assessment of LDL and HDL receptor activities in various cell types.
- Enzyme activity assays for acyl CoA cholesterol acyl transferase, neutral cholesterol ester hydrolase, ATP dependent citrate lyase, and others.
- Analysis of biliary cholesterol and bile salt levels.
- Acute toxicity studies (LD50) in mice.
Main Results:
- 2-Furoic acid significantly reduced serum cholesterol and triglyceride levels, increasing HDL cholesterol in rats.
- It inhibited LDL receptor activity and enhanced HDL receptor activity in specific cells.
- The compound inhibited acyl CoA cholesterol acyl transferase and other key lipid-metabolizing enzymes in vivo.
- Bile salt levels increased, while biliary cholesterol decreased.
- Acute toxicity studies indicated hepatic effects with an LD50 of 250 mg/kg IP in mice.
Conclusions:
- 2-Furoic acid exerts its lipid-lowering effects by directly modulating intracellular enzyme activities rather than lipoprotein receptors.
- The compound influences multiple enzymes in cholesterol and triglyceride synthesis and metabolism.
- Potential for hepatic toxicity and increased lithogenicity of bile should be considered.